BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29689706)

  • 1. Serological TK1 predict pre-cancer in routine health screenings of 56,178 people.
    Wang Y; Jiang X; Wang S; Yu H; Zhang T; Xu S; Li W; He E; Skog S
    Cancer Biomark; 2018; 22(2):237-247. PubMed ID: 29689706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum TK1 is a more reliable marker than CEA and AFP for cancer screening in a study of 56,286 people.
    Wang Y; Jiang X; Dong S; Shen J; Yu H; Zhou J; Li J; Ma H; He E; Skog S
    Cancer Biomark; 2016 Mar; 16(4):529-36. PubMed ID: 27002755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological thymidine kinase 1 is a biomarker for early detection of tumours--a health screening study on 35,365 people, using a sensitive chemiluminescent dot blot assay.
    Chen ZH; Huang SQ; Wang Y; Yang AZ; Wen J; Xu XH; Chen Y; Chen QB; Wang YH; He E; Zhou J; Skog S
    Sensors (Basel); 2011; 11(12):11064-80. PubMed ID: 22247653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum thymidine kinase 1 predicts risk of pre/early cancerous progression.
    Huang S; Lin J; Guo N; Zhang M; Yun X; Liu S; Zhou J; He E; Skog S
    Asian Pac J Cancer Prev; 2011; 12(2):497-505. PubMed ID: 21545220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymidine kinase activity in serum of renal cell carcinoma patients is a useful prognostic marker.
    Luo P; He E; Eriksson S; Zhou J; Hu G; Zhang J; Skog S
    Eur J Cancer Prev; 2009 Jun; 18(3):220-4. PubMed ID: 19282758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymidine kinase 1 is a potential marker for prognosis and monitoring the response to treatment of patients with breast, lung, and esophageal cancer and non-Hodgkin's lymphoma.
    He E; Xu XH; Guan H; Chen Y; Chen ZH; Pan ZL; Tang LL; Hu GZ; Li Y; Zhang M; Zhou J; Eriksson S; Fornander T; Skog S
    Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):352-8. PubMed ID: 20544519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum thymidine kinase 1 is a reliable maker for the assessment of the risk of developing malignancy: A case report.
    Chen Z; Guan H; Yuan H; Cao X; Liu Y; Zhou JI; He E; Skog S
    Oncol Lett; 2015 Sep; 10(3):1669-1673. PubMed ID: 26622729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer.
    Jiang ZF; Wang M; Xu JL
    Life Sci; 2018 Feb; 194():1-6. PubMed ID: 29247745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of serum thymidine kinase 1 of 26 055 cases in health screening for early detection of premalignant/early malignant tumors].
    Cao X; Wang Y; Yang P; Zhou H; Liu C; Chen Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Oct; 39(10):1029-34. PubMed ID: 25355255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological thymidine kinase 1 (STK1) indicates an elevated risk for the development of malignant tumours.
    Chen Z; Zhou H; Li S; He E; Hu J; Zhou J; Skog S
    Anticancer Res; 2008; 28(6B):3897-907. PubMed ID: 19192647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is serum thymidine kinase 1 a prognostic biomarker in primary tumor location of colorectal carcinomas?
    Fang Y; Skog S; Ou Q; Chen Z; Liu S; Hei A; Li J; Zhou J; He E; Wan D
    Discov Oncol; 2023 Feb; 14(1):21. PubMed ID: 36800051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoembryonic antigen, alpha-fetoprotein, and prostate-specific antigen in the sera of industrial workers exposed to phenol, formaldehyde, urea, and mixed vapors.
    El Far M; El Naggar M; Elkhawaga OA; Yahya R; Allam A; Khalifa A
    Inhal Toxicol; 2006 Dec; 18(13):1041-6. PubMed ID: 16966304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The proliferation marker thymidine kinase 1 in clinical use.
    Zhou J; He E; Skog S
    Mol Clin Oncol; 2013 Jan; 1(1):18-28. PubMed ID: 24649117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum detection of thymidine kinase 1 as a means of early detection of lung cancer.
    Alegre MM; Weyant MJ; Bennett DT; Yu JA; Ramsden MK; Elnaggar A; Robison RA; O'Neill KL
    Anticancer Res; 2014 May; 34(5):2145-51. PubMed ID: 24778016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib.
    Bagegni N; Thomas S; Liu N; Luo J; Hoog J; Northfelt DW; Goetz MP; Forero A; Bergqvist M; Karen J; Neumüller M; Suh EM; Guo Z; Vij K; Sanati S; Ellis M; Ma CX
    Breast Cancer Res; 2017 Nov; 19(1):123. PubMed ID: 29162134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker.
    Jagarlamudi KK; Hansson LO; Eriksson S
    BMC Cancer; 2015 Feb; 15():66. PubMed ID: 25881026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentration of thymidine kinase 1 in serum (S-TK1) is a more sensitive proliferation marker in human solid tumors than its activity.
    He Q; Zhang P; Zou L; Li H; Wang X; Zhou S; Fornander T; Skog S
    Oncol Rep; 2005 Oct; 14(4):1013-9. PubMed ID: 16142366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum thymidine kinase 1 levels predict cancer-free survival following neoadjuvant, surgical and adjuvant treatment of patients with locally advanced breast cancer.
    Chen F; Tang L; Xia T; He E; Hu G; Li Y; Zhang M; Zhou J; Eriksson S; Skog S
    Mol Clin Oncol; 2013 Sep; 1(5):894-902. PubMed ID: 24649267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Novel Recombinant Full-Length IgY Monoclonal Antibody against Human Thymidine Kinase 1 for Automatic Chemiluminescence Analysis on a Sandwich Biotin-Streptavidin Platform for Early Tumour Discovery.
    Wang X; Li S; Zhao R; Li H; Gao P; Jin C; Fang C; Liu Y; Hei A; Zhou J; Li J; He E; Skog S
    J Immunol Res; 2023; 2023():7612566. PubMed ID: 36969497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STK1p as a prognostic biomarker for overall survival in non-small-cell lung carcinoma, based on real-world data.
    Wang Z; Zhang G; Li Z; Li J; Ma H; Hei A; Jiao S; Hu Y; Sun S; Wu L; Zhou J; Wang Y; He E; Skog S
    Future Sci OA; 2020 Nov; 7(3):FSO661. PubMed ID: 33552542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.